Literature DB >> 22950558

Laser use in infantile hemangiomas, when and how.

N Bruscino1, P Bonan, G Cannarozzo, S Moretti, T Lotti, P Campolmi.   

Abstract

Infantile hemangiomas (IHs) are proliferating embrional tumors which can stem from placented tissue and are constituted by endothelial cell hyperproliferation. The management of the IHs is always challenging for all the specialists because of the heterogeneous behavior of these lesions. The factors leading to an aggressive position are essentially these: the prevention or reduction of aesthetic risks, the prevention or treatment of ulcerated hemangiomas, the prevention or impairment of functional risks and pain, and the removal of life-threatening risks. The treatment of vascular lesions is one of the mostly sought and performed cutaneous laser procedures, and in the field of IH treatments the more used laser devices certainly are pulsed dye lasers. Early laser therapy is able to reduce the possibility that the lesion will reach its full size, preventing several complications, connected to the hemangioma's growth, and providing psychological relief for pediatric patients and their parents.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22950558     DOI: 10.1111/j.1529-8019.2012.01466.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  3 in total

1.  Efficacy Evaluation of 755-nm Long-Pulse Alexandrite Laser Combined with 0.5% Timolol Maleate Eye Drops in the Treatment of Thicker Infantile Hemangioma.

Authors:  Jianming Wu; Fangyan Zhou; Yu Gao
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-11-09

2.  Noteworthy effects of a long-pulse Alexandrite laser for treatment of high-risk infantile hemangioma: A case report and literature review.

Authors:  Wen-Ting Su; Ji-Xin Xue; You-Hui Ke
Journal:  World J Clin Cases       Date:  2019-07-26       Impact factor: 1.337

Review 3.  Current perspectives on the optimal management of infantile hemangioma.

Authors:  Peter Grzesik; June K Wu
Journal:  Pediatric Health Med Ther       Date:  2017-12-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.